Advance Directive Utilization Is Associated with Less Aggressive End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION Cappell, K., Sundaram, V., Park, A., Shiraz, P., Gupta, R., Jenkins, P., Periyakoil, V. J., Muffly, L. 2018; 24 (5): 1035–40

View details for DOI 10.1016/j.bbmt.2018.01.014

View details for Web of Science ID 000433400000021